-- 根據其母公司國藥集團（HKG:1099）週二在香港聯交所提交的文件顯示，中國國康醫藥（上海證券交易所代碼：000028，200028）截至3月31日的三個月內，歸屬於母公司的淨利潤同比下降12%，從去年同期的3.28億元降至2.875億元。 該公司基本每股收益從去年同期的0.59元降至0.52元。 營收年減2.6%，從去年同期的183億元降至178億元。
Related Articles
Asia
Federal Court Fines Solvar Unit Receives AU$1.6 Million
Solvar (ASX:SVR) said that the Federal Court of Australia ordered the firm's unit Money3 Loans to pay a pecuniary penalty in the sum of nearly AU$1.6 million, according to a Monday Australian bourse filing.The court's decision was in relation to the penalty payable for the contraventions of the National Consumer Credit Act during the period from 2019 to 2021."Since the period in question, Money3 has invested further in its governance, complaints, hardship, and underwriting practices," Solvar Chief Executive Scott Baldwin said.
$ASX:SVR
Asia
Hangzhou Changchuan Technology Q1 Profit jumps 218%; Shares Rise 3%
Hangzhou Changchuan Technology (SHE:300604) posted first-quarter attributable net profit of 352.5 million yuan, up 218% from 111.0 million yuan the previous year.Earnings per share rose to 0.5472 yuan from 0.1756 yuan, according to a weekend filing with the Shenzhen bourse.Operating revenue rose 69% year over year to 1.38 billion yuan from 815.3 million yuan.Shares of the semiconductor test equipment company rose 3% in recent trade.
$SHE:300604
Asia
Dawning Information's Profit Jumps 22% in Q1, Revenue Rises 24%
Dawning Information Industry's (SHA:603019) net profit attributable to shareholders in the first quarter jumped 22% to 227.8 million yuan, or 0.156 yuan per share, according to a Saturday filing on the Shanghai bourse.The supercomputer manufacturer's shares rose 2% in morning trade on Monday.Operating revenue rose 24% to 3.20 billion yuan from 2.59 billion yuan in the prior year.
$SHA:603019